[Fidanacogene elaparvovec (haemophilia B); assessment according to §35a Social Code Book (SGB) V; search for disease registries]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005239
German
Original Title:
Fidanacogen Elaparvovec (Hämophilie B)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/i23-06.html
Year Published:
2023
URL for published report:
https://www.iqwig.de/download/i23-06_fidanacogen-elaparvovec_recherche-nach-indikationsregistern_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
DOI:
10.60584/I23-06
MeSH Terms
- Hemophilia B
- Registries
- Product Surveillance, Postmarketing
- Genetic Therapy
Keywords
- Fidanacogene Elaparvovec
- Hemophilia B
- Registries
- Product Surveillance – Postmarketing
- Information Storage and Retrieval
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.